Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm

In response to the coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), global efforts are focused on the development of new therapeutic interventions. For the treatment of COVID-19, selective lung-localizing strategies hold tremendous po...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyelim, Lee, Han Sol, Ahn, June Hong, Hong, Kyung Soo, Jang, Jong Geol, An, Jiseon, Mun, Yong-Hyeon, Yoo, So-Yeol, Choi, Yoon Jung, Yun, Mi-Young, Song, Gyu Yong, Joo, Jinmyoung, Na, Dong Hee, Kim, Hong Nam, Park, Hee Ho, Lee, Jae-Young, Lee, Wonhwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026257/
https://www.ncbi.nlm.nih.gov/pubmed/33846686
http://dx.doi.org/10.1016/j.nantod.2021.101149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026257/
https://www.ncbi.nlm.nih.gov/pubmed/33846686
http://dx.doi.org/10.1016/j.nantod.2021.101149

Ejemplares similares